We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$423M
AUM Growth
-$85.6M
Cap. Flow
-$118M
Cap. Flow %
-27.88%
Top 10 Hldgs %
66.33%
Holding
83
New
3
Increased
17
Reduced
15
Closed
37

Top Buys

Rank Stock Value
1
CNNE icon
Cannae Holdings
CNNE
+$14.6M
2
GTX icon
Garrett Motion
GTX
+$11.9M
3
CIO
City Office REIT
CIO
+$8.27M
4
MBI icon
MBIA
MBI
+$2.91M
5
VTOL icon
Bristow Group
VTOL
+$2.74M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.61%
2 Healthcare 22.7%
3 Communication Services 13.35%
4 Real Estate 8.73%
5 Technology 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPLI
1
People Inc
PPLI
$3.1B
$56.5M 13.35%
1,097,100
-7,113
-0.6% -$326K
CNNE icon
2
Cannae Holdings
CNNE
$647M
$40.6M 9.6%
2,010,663
+760,663
+61% +$14.6M
GIII icon
3
G-III Apparel Group
GIII
$1.47B
$31.7M 7.49%
1,645,452
+105,827
+7% +$1.82M
PAR icon
4
PAR Technology
PAR
$637M
$29.6M 7%
900,000
-47,071
-5% -$1.57M
AMBP icon
5
Ardagh Metal Packaging
AMBP
$2.86B
$26.3M 6.22%
7,000,000
MACK
6
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$23M 5.44%
1,873,694
SPB icon
7
Spectrum Brands
SPB
$2.04B
$19.5M 4.61%
249,937
VTOL icon
8
Bristow Group
VTOL
$1.35B
$19.4M 4.58%
674,270
+114,857
+21% +$2.74M
CIO
9
DELISTED
City Office REIT
CIO
$17M 4.03%
3,059,721
+1,515,601
+98% +$8.27M
TBPH icon
10
Theravance Biopharma
TBPH
$874M
$17M 4.01%
1,640,456
+109,441
+7% +$1.21M
ONL
11
Orion Office REIT
ONL
$148M
$15.1M 3.58%
2,290,000
+97,884
+4% +$610K
MBI icon
12
MBIA
MBI
$288M
$12.1M 2.85%
1,395,000
+322,898
+30% +$2.91M
GTX icon
13
Garrett Motion
GTX
$5.9B
$11.2M 2.65%
+1,482,149
New +$11.9M
LKFT
14
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$11M 2.59%
270,000
+1,718
+0.6% +$70.1K
PHAT icon
15
Phathom Pharmaceuticals
PHAT
$912M
$9.79M 2.31%
683,648
+1,621
+0.2% +$18.7K
TSVT
16
DELISTED
2seventy bio
TSVT
$7.47M 1.76%
737,744
-767,256
-51% -$8.12M
NODK icon
17
NI Holdings
NODK
$325M
$6.83M 1.61%
460,000
+29,102
+7% +$396K
KOD icon
18
Kodiak Sciences
KOD
$2.59B
$6.83M 1.61%
989,703
+96,968
+11% +$593K
TLYS icon
19
Tilly's
TLYS
$115M
$5.61M 1.32%
800,000
+80,849
+11% +$593K
DXLG icon
20
Destination XL Group
DXLG
$34.7M
$5.39M 1.27%
1,100,000
+35,000
+3% +$164K
STHO icon
21
Star Holdings Shares of Beneficial Interest
STHO
$112M
$4.76M 1.12%
324,472
-2
-0% -$32
PCG icon
22
PG&E
PCG
$47.8B
$4.65M 1.1%
268,921
FET icon
23
Forum Energy Technologies
FET
$654M
$4.61M 1.09%
180,000
+1,900
+1% +$45K
ASTL icon
24
Algoma Steel
ASTL
$455M
$4.2M 0.99%
590,899
ETNB
25
DELISTED
89bio
ETNB
$3.79M 0.9%
200,000

Similar funds

Newtyn Management's Q2 2023 Portfolio in Review

As of Q2 2023, Newtyn Management held 83 positions worth $423M, down 17% from $509M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Newtyn Management withdrew a net $118M in Q2 2023, closing 37 positions and reducing 15 holdings. Its most notable exit was Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Newtyn Management opened a new position in Garrett Motion worth $11.2M.

  • Newtyn Management's largest Q2 2023 buy was Garrett Motion: 1,482,149 shares worth $11.2M.
  • Newtyn Management added most to Cannae Holdings in Q2 2023, an estimated $14.6M increase.
  • Newtyn Management's biggest Q2 2023 reduction was Lamb Weston, cutting an estimated $15.4M.
  • Newtyn Management fully exited Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock in Q2 2023, selling an estimated $15.1M.
  • Newtyn Management's ten largest holdings make up 66% of its $423M portfolio in Q2 2023.
  • Newtyn Management opened 3 new positions and closed 37 in Q2 2023.
  • Newtyn Management's portfolio value fell 17% quarter-over-quarter to $423M.

Based on Newtyn Management's 13F filing for Q2 2023, filed 14 Aug 2023.